Colin Goldschmidt - Sonic Healthcare CEO

SKHCF Stock  USD 16.90  0.63  3.59%   

CEO

Dr. Colin S. Goldschmidt, M.D. is an Chief Executive Officer, Managing Director, Executive Director of Sonic Healthcare Limited. Dr Goldschmidt is the CEO and Managing Director of Sonic Healthcare. He is a qualified medical doctor who then undertook specialist pathology training in Sydney, before gaining his qualification as a specialist pathologist in 1986. Dr Goldschmidt became CEO of Sonic in 1993 and has led Sonics global expansion by committing the Company to a model of Medical Leadership, which incorporates unique operational and cultural attributes. He is a member of Sonics Risk Management Committee and holds memberships with numerous industry, medical and laboratory associations. since 2014.
Age 63
Tenure 10 years
Professional MarksPh.D
Phone61 2 9855 5444
Webhttps://www.sonichealthcare.com

Sonic Healthcare Management Efficiency

The company has return on total asset (ROA) of 0.1111 % which means that it generated a profit of $0.1111 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2175 %, meaning that it generated $0.2175 on every $100 dollars invested by stockholders. Sonic Healthcare's management efficiency ratios could be used to measure how well Sonic Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 1.58 B in total debt with debt to equity ratio (D/E) of 0.41, which is about average as compared to similar companies. Sonic Healthcare has a current ratio of 1.09, suggesting that it may have difficulties to pay its financial obligations in time and when they become due. Debt can assist Sonic Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Sonic Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sonic Healthcare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sonic to invest in growth at high rates of return. When we think about Sonic Healthcare's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 7 records

CEO Age

Scott HuttonBiodesixInc
52
Timothy DamadianFonar
60
Harry SimeonidisIntelligent Bio Solutions
57
Christopher ThatcherNeuronetics
53
Ilan DanieliPrecipio
52
Keith SullivanNeuronetics
66
Chris ThatcherNeuronetics
N/A
Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia. SONIC HEALTHCARE operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 41000 people. Sonic Healthcare Limited [SKHCF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Sonic Healthcare Leadership Team

Elected by the shareholders, the Sonic Healthcare's board of directors comprises two types of representatives: Sonic Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sonic. The board's role is to monitor Sonic Healthcare's management team and ensure that shareholders' interests are well served. Sonic Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sonic Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Julian Adler, Chief Imaging
Mrs Schottdorf, Chief Group
Neville Mitchell, Non-Executive Independent Director
BEc CA, Deputy Sec
Louis Panaccio, Non-Executive Independent Director
Colin Goldschmidt, CEO, Managing Director, Investor Relations Contact Officer, Executive Director
Peter Savage, Chief Officer
Elizabeth Wilson, Independent Non-Executive Director
Philip Dubois, Executive Director
Kathryn Spargo, Non-Executive Independent Director
Stephen Fairy, Global Officer
Christopher Wilks, Finance Director, Executive Director
FAICD FRCPA, MD CEO
BCom FACID, CFO Director
David Byrne, Chief Laboratory
Prashan Kulasekera, Assistant Sec
Mark Compton, Non-Executive Independent Director
Paul Alexander, Company Secretary

Sonic Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sonic Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonic Healthcare Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Sonic Healthcare information on this page should be used as a complementary analysis to other Sonic Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Sonic Pink Sheet analysis

When running Sonic Healthcare's price analysis, check to measure Sonic Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonic Healthcare is operating at the current time. Most of Sonic Healthcare's value examination focuses on studying past and present price action to predict the probability of Sonic Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonic Healthcare's price. Additionally, you may evaluate how the addition of Sonic Healthcare to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Please note, there is a significant difference between Sonic Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonic Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonic Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.